- Home
- CLDI vs LDWY Comparison
CLDI vs LDWY Comparison
Compare CLDI & LDWY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLDI
- LDWY
- Stock Information
- Founded
- CLDI 2014
- LDWY 1990
- Country
- CLDI United States
- LDWY United States
- Employees
- CLDI N/A
- LDWY N/A
- Industry
- CLDI Biotechnology: Biological Products (No Diagnostic Substances)
- LDWY Advertising
- Sector
- CLDI Health Care
- LDWY Consumer Discretionary
- Exchange
- CLDI Nasdaq
- LDWY Nasdaq
- Market Cap
- CLDI 10.2M
- LDWY 9.2M
- IPO Year
- CLDI N/A
- LDWY 1991
- Fundamental
- Price
- CLDI $0.71
- LDWY $4.79
- Analyst Decision
- CLDI
- LDWY
- Analyst Count
- CLDI 0
- LDWY 0
- Target Price
- CLDI N/A
- LDWY N/A
- AVG Volume (30 Days)
- CLDI 41.3M
- LDWY 3.4K
- Earning Date
- CLDI 08-12-2025
- LDWY 08-18-2025
- Dividend Yield
- CLDI N/A
- LDWY N/A
- EPS Growth
- CLDI N/A
- LDWY N/A
- EPS
- CLDI N/A
- LDWY N/A
- Revenue
- CLDI N/A
- LDWY $42,183,000.00
- Revenue This Year
- CLDI N/A
- LDWY N/A
- Revenue Next Year
- CLDI N/A
- LDWY N/A
- P/E Ratio
- CLDI N/A
- LDWY N/A
- Revenue Growth
- CLDI N/A
- LDWY 425.12
- 52 Week Low
- CLDI $0.20
- LDWY $3.02
- 52 Week High
- CLDI $3.89
- LDWY $5.53
- Technical
- Relative Strength Index (RSI)
- CLDI 65.65
- LDWY 60.30
- Support Level
- CLDI $0.23
- LDWY $4.56
- Resistance Level
- CLDI $1.60
- LDWY $5.23
- Average True Range (ATR)
- CLDI 0.15
- LDWY 0.22
- MACD
- CLDI 0.07
- LDWY 0.00
- Stochastic Oscillator
- CLDI 36.55
- LDWY 89.52
About CLDI Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in a many oncology indications, including high-grade gliomas and solid tumors. Its products include CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-400 for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline products, the Company's is also engaged in discovery research of CLD-301 (AAA) for tumor Indications.
About LDWY Lendway Inc. (DE)
Lendway Inc is a specialty agricultural and finance company focused on making and managing its ag investments in the United States and internationally. The company operates in two industries: Specialty Ag, consisting of the Bloomia business, and Non-bank Lending, consisting of the Lending Business.